Summary
The activity of two proteases associated with tumour cells was studied using frozen sections of squamous-cell carcinoma and fluorescent probes for the enzymes. Four fluorescent probes were used to define the enzymic status of guanidinobenzoatase on the surface of the squamous carcinoma cells. Each of four probes demonstrated the location of cells possessing inactive guanidinobenzoatase, whereas adjacent cells of the same tumour exhibited active enzyme. It was shown that the inactive form of the enzyme was an inhibitor-enzyme complex that could be dissociated. In contrast, all of the squamous carcinoma cells possessed active trypsin-like enzymes that were recognised by fluorescent aprotinin molecules. The observed variation in enzymic status of these two tumour-associated enzyme systems is discussed in the context of a possible biological control mechanism for cell migration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cajot JF, Kruithof EKO, Schleuning WD, Sordat B, Bachman F (1986) Plasminogen activators, plasminogen activator inhibitors and procoagulant analysed in twenty human tumour lines. Int J Cancer 38(5):719–727
Coleman PL, Lathman HG, Shaw EN (1976) Some sensitive methods for the assay of trypsin-like enzymes. Methods Enzymol 45:12–26
Feichter GE, Maier H, Adler D, Born A, Abel U, Haag D, Goerttler K (1987)S-phase fractions and DNA-ploidy of otopharyngeal squamous epithelium carcinomas compared with histologic grade, stage, response to chemotherapy and survival. Acta Otolaryngol (Stockh) 104:377–384
Geiger M, Binder BR (1987) Tissue type plasminogen activator and cytokinase: differences in the reaction pattern with the activesite titrant 4-methyl-umbelliferyl-p-guanidinobenzoatase hydrochloride. Biochem Biophys Acta 912:34–40
Laiho M, Saksela O, Andreasen PA, Keski-Oja J (1986) Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor beta. J Cell Biol 103(6):2403–2410
Leytus SP, Melhado LL, Mangel WF (1983) Rhodamine based compounds as fluorogenic substrates for serine proteases. Biochem J 209:299–307
Moscatelli D, Rifkin DB (1988) Membrane and matrix localization of proteinases: a common theme in tumour cell invasion and angiogenesis. Biochem Biophys Acta 948:67–85
Ossowski L, Quigley JP, Reich E (1974) Fibrinolysis associated with oncogenic transformation. J Biol Chem 249:4812–4320
Pierschbacher MD, Ruoslahti E (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30–33
Steven FS, Al-Ahmad RK (1983) Evidence for an enzyme which cleaves the guanidinobenzoate moiety from active site titrants specifically designed to inhibit and quantify trypsin. Eur J Biochem 130:335–339
Steven FS, Ali H, Griffin MM (1988a) The inhibition of a tumour cell surface protease in vivo and its re-activation by oxidation. Br J Cancer 57:160–164
Steven FS, Griffing MM (1988b) Inhibitors of guanidinobenzoatase and their possible role in cell migration. Biol Chem Hoppe Seyler 369[Suppl]:137–143
Steven FS, Griffin MM, Al-Ahmad RK (1985) The design of fluorescent probes which bind to the active centre of guanidinobenzoatase. Application to the location of cells possessing this enzyme. Eur J Biochem 149:35–40
Steven FS, Griffin MM, Wong TLH, Itzhaki S (1986) Evidence for inhibitors of the cell surface protease guanidinobenzoatase. J Enzyme Inhib 1:127–137
Steven FS, Griffin MM, Freemont AJ, Johnson J (1988a) Inhibition of guanidinobenzoatase: evidence for multiple forms of this protease on different tumour cells. J Enzyme Inhib 2:117–127
Steven FS, Griffin MM, Maier H, Weidauer H, Mangel WF, Altmannsberger M (1988b) Studies on the activity of a protease associated with cells at the advancing edge of human tumour masses in frozen sections. Br J Cancer 58:57–60
Steven FS, Griffin MM, Mangel WF, Maier H, Altmannsberger M (1988c) Inhibition of guanidinobenzoatase by a substrate for trypsin-like enzymes. J Enzyme Inhib 2:209–214
Steven FS, Griffin MM, Williams LA, Freemont AJ, Maier H, Weidauer H (1989d) Inhibition of trypsin-like enzymes on cells with rhodamine-aprotinin. J Enzyme Inhib 2:295–303
Steven FS, Griffin MM, Williams LA, Ali H, Maier H (1989a) Targeting Adriamycin to tumour cells by means of an affinity ligand: a model system for drug delivery. Anticancer Res (in press)
Steven FS, Griffin MM, Williams LA, Feichter G (1989b) A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells. Anticancer Res (in press)
Trautschold I, Werle E, Zickgraf-Rudel G (1967) Trasylol. Biochem Pharmacol 16:57–72
Unkeles J, Dano K, Kellerman GM, Reich E (1974) Fibrinolysis associated with oncogenic transformation. J Biol Chem 249:4295–4305
Urano T, Urano S, Castellano FJ (1988) Reaction of tissue-type plasminogen activator with 4-methylumbelliferyl-p-guanidinobenzoate HC1. Biochem Biophys Res Commun 150:45–51
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steven, F.S., Williams, L.A., Maier, H. et al. The status of trypsin-like enzymes in squamous-cell carcinoma of the head and neck region. J Cancer Res Clin Oncol 116, 57–64 (1990). https://doi.org/10.1007/BF01612641
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01612641